Co-founder of biomedical giant Biomet donates $10M to Rose-Hulman
Rose-Hulman, which offers the country’s top-rated undergraduate engineering program, said the gift was among the largest individual donations in institute history.
Rose-Hulman, which offers the country’s top-rated undergraduate engineering program, said the gift was among the largest individual donations in institute history.
Zimmer Biomet Holdings Inc. said it has completed its first surgical case using a new device called a comprehensive augmented baseplate, which offers an alternative to bone grafting for patients with defects in the shoulder cavity who are undergoing shoulder reconstruction.
The Indiana-based company has taken the name Zimmer Biomet Holdings Inc. and will trade under the ticker symbol to "ZBH" on Monday. Zimmer Holdings Inc. agreed to buy privately-held Biomet in April 2014.
Orthopedic device maker Zimmer said Thursday it will be called Zimmer Biomet after its combination with privately held competitor Biomet.
Slowing domestic growth pushes executives to brighter markets.
Attempts to build the sector are making headway, but Indiana still lags leading states.
The deal will help Zimmer, a maker of artificial hips and knees, take on Johnson & Johnson, the No. 1 manufacturer in the now-growing $45 billion market.
Biomet’s project calls for building renovations and adding 3-D printing and optical scanning technology. The Warsaw-based company would also upgrade an incubation center for surgeons interested in introducing a new product, technology or technique.
Indiana-based Biomet Group Inc., a closely held maker of orthopedic medical devices, had been publicly traded until 2007 when it was acquired by the group of private equity firms.
Indiana-based Biomet Inc. has agreed to pay a base rate of $200,000 each to hundreds of people who received artificial hips that were later replaced.
The skies got a little brighter for the orthopedic industry on Friday after Warsaw-based Biomet Inc. reported strong quarterly sales growth of 3.4 percent. That news sparked a small surge in the stock prices of two other Warsaw-based orthopedics companies.
Warsaw-based Biomet, which designs and manufactures orthopedic products for surgical and non-surgical uses, said the deal would greatly expand its sports, extremities and trauma business.
Indiana-based Biomet Inc. has agreed to pay $22.7 million to settle U.S. criminal and civil allegations that it bribed government-employed doctors in Argentina, Brazil and China for eight years to win business with hospitals.
Warsaw-based Biomet Inc. could get a whole lot bigger if rumors prove true that its owners have made a bid for U.K.-based rival Smith & Nephew plc.
Biomet’s quarterly results are considered an indicator on the state of the orthopedic device industry because it reports results before most of its competitors.
Orthopedics giant Biomet Inc. plans to invest $26 million to grow operations in its hometown of Warsaw, adding 278 jobs by
the end of 2012.